You searched for T cells - Page 27 of 41

Startup Scout 6 Sep 2023

Meet the startup developing novel cancer therapies from snake venom crotoxin

…that has an inbuilt targeting mechanism and selectivity for tumor cells. The therapy contains two subunits: A and B. “Once injected into the body via infusion pump, the A subunit…

September 6, 2023 - 7 minutesmins - By Willow Shah-Neville

News and Trends 27 Nov 2017

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

…phagocytic cells to remove pathogens, could be a candidate to quickly take care of the infection. Complement coats the virus, making it easier for the immune system to detect and…

November 27, 2017 - 3 minutesmins - By Alex Dale

News and Trends 27 Mar 2018

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

…whether a tumor is benign or malignant. “There are several major advantages to the circulating tumor cell technology. The first is it’s epitope or label-independent, so it doesn’t require the…

March 27, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 31 May 2017

German Biotech Enters the Clinic with Next-Generation Antibody for AML

…immuno-oncology candidate targeting the TRAIL-receptor. Apart from that, CAR-T pioneers such as Cellectis and Celyad or Juno are racing to treat leukemia including AML or ALL using their engineered killer…

May 31, 2017 - 2 minutesmins - By Melanie De Almeida

blood cancer stem cell therapy brain cancer

News and Trends 11 Sep 2019

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

…cells. In the lab, Genenta makes the stem cells mature into immune cells called tumor-infiltrating monocytes, and the company implants them into the patient’s tumor where they can recruit the…

September 11, 2019 - 3 minutesmins - By Jonathan Smith

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

…cells to treat cancer. The two companies will assess the combination therapies’ performances in preclinical studies next year. The FLEX-NK antibodies are based on a tetravalent, multifunctional format with flexible…

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…of CAR-T cell therapy and T-cell receptor technologies. Both approaches have shown great promise for cancer treatment, with the two first CAR-T therapies launched into the market in 2017. To…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 2 May 2017

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

…Celyad’s allogeneic CAR-T therapy. By using T cells derived from a healthy donor, allogeneic CAR-T therapy is thought to be more cost- and time-effective, allowing for off-the-shelf available T cells…

May 2, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 9 Jan 2018

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

…for the treatment of cancer and it has announced that it will come together with Europe’s largest private biopharma, BioNTech, to develop T-cell receptor (TCR)-based therapies. In particular, the collaboration…

January 9, 2018 - 3 minutesmins - By Alex Dale

News and Trends 29 Sep 2016

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

…are now advancing their programs in CAR-T, the breakthrough therapy that everyone’s after. In this treatment, the patient’s T-cells are engineered in vitro, rewired to attack a specific tumor antigen…

September 29, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

In Depth 15 Feb 2024

Turning the tide: recent advancements in childhood cancer research

…Last year, BrainChild took its CAR-T candidate to the clinic to evaluate four different targets. It plans to create a CAR-T cell therapy platform that can address multiple targets, include…

February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 13 May 2022

Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy

…are proteins on the surface of immune T cells that normally prevent an immune response from being so strong it destroys healthy cells in the body. Cancer cells can exploit…

May 13, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

Meet the startup developing novel cancer therapies from snake venom crotoxin

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

German Biotech Enters the Clinic with Next-Generation Antibody for AML

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

Turning the tide: recent advancements in childhood cancer research

Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!